Product Name: PKG2 (422-440)
Product Number: PE-01BEX70
| Size: | 200 µg | Price: | 14.00 | |
| 1 mg | $US | 29.00 | ||
| 5 mg | 78.00 |
Peptide Name: PKG2 (422-440)
Product Use: Services as a blocking peptide for use with the PKG2-BKCD rabbit polyclonal antibody (Cat. No.: AB-NK290-2) that is also available from Kinexus. The peptide sequence is located just before the kinase catalytic domain.
Peptide Production Method: Solid-phase peptide synthesis
Peptide Origin: Homo sapiens
Peptide Sequence: CSNWKLSKALSLEMIQLKEK
Peptide Modifications N Terminus: Free amino
Peptide Modifications C Terminus: Amide
Peptide Molecular Mass Calculated: 2348.8 Da
Peptide Purity Percent after Synthesis and Purification: >50
Product Use: Services as a blocking peptide for use with the PKG2-BKCD rabbit polyclonal antibody (Cat. No.: AB-NK290-2) that is also available from Kinexus. The peptide sequence is located just before the kinase catalytic domain.
Peptide Production Method: Solid-phase peptide synthesis
Peptide Origin: Homo sapiens
Peptide Sequence: CSNWKLSKALSLEMIQLKEK
Peptide Modifications N Terminus: Free amino
Peptide Modifications C Terminus: Amide
Peptide Molecular Mass Calculated: 2348.8 Da
Peptide Purity Percent after Synthesis and Purification: >50
Peptide Appearance: White powder
Peptide Form: Solid
Storage Conditions: -20°C
Related Product 1: PKG2 pan-specific antibody (Cat. No.: AB-NK290-2)
Peptide Form: Solid
Storage Conditions: -20°C
Related Product 1: PKG2 pan-specific antibody (Cat. No.: AB-NK290-2)
Scientific Background: PKG2 (PRKG2) is a protein-serine/threonine kinase of the AGC group and PKG family. It is activated by cGMP. PKG2 may be a target in the treatment of colon cancer.
© Kinexus Bioinformatics Corporation 2017